OTC Markets EXMKT - Delayed Quote USD

Eagle Pharmaceuticals, Inc. (EGRX)

Compare
0.7000
+0.1750
+(33.33%)
At close: January 10 at 3:57:50 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,318.0000
50,701.0000
28,219.0000
49,497.0000
Investing Cash Flow
-23,810.0000
-86,830.0000
-5,323.0000
-18,247.0000
Financing Cash Flow
11,920.0000
-6,209.0000
-28,392.0000
-37,870.0000
End Cash Position
15,354.0000
55,321.0000
97,659.0000
103,155.0000
Income Tax Paid Supplemental Data
37,197.0000
28,410.0000
10,005.0000
6,428.0000
Interest Paid Supplemental Data
4,060.0000
1,726.0000
1,197.0000
2,224.0000
Capital Expenditure
-74.0000
-178.0000
-323.0000
-747.0000
Issuance of Debt
110,000.0000
80,000.0000
--
110,000.0000
Repayment of Debt
-85,736.0000
-67,236.0000
-8,000.0000
-115,000.0000
Repurchase of Capital Stock
-9,951.0000
-18,004.0000
-21,213.0000
-34,999.0000
Free Cash Flow
-9,392.0000
50,523.0000
27,896.0000
48,750.0000
12/31/2020 - 2/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers